A critically important national, multi-institutional clinical trial is underway, and the CTSI is part of it, all in the hopes of finding an effective treatment today and perhaps in the future. Learn about the CONTAIN COVID Convalescent Plasma clinical trial, inside this edition of CTSI Discovery Radio!
Guests
Christopher P. Austin, MD
Director, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH)
Rahul Nanchal, MD
Professor, Department of Medicine (Pulmonary), MCW; Co-Principal Investigator, CONTAIN COVID, F&MCW
Gilbert C. White, II, MD
Executive Vice President for Research, VBRI; Professor, Department of Medicine (Biochemistry, and Pharmacology & Toxicology), MCW
NIH Funding Acknowledgment:Important Reminder – Please acknowledge the NIH when publishing papers, patents, projects, and presentations resulting from the use of CTSI resources by including the NIH Funding Acknowledgement.
